Genenta Science S.p.A. (SAEN) stock
SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA
$0.60−0.05 (-7.66%)
Close on Nov 16, 2026Market cap $14.06MP/E –Yield –
Genenta Science S.p.A. cash
Cash and short-term investments held at the end of each period.
Genenta Science S.p.A.'s cash was €28.15M at Dec 31, 2025. For fiscal 2025 it was €28.15M, up 121.6% from the year before. The highest annual figure on record is €37.24M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €28.15M | +121.6% |
| FY2024 | Dec 31, 2024 | €12.70M | -32.4% |
| FY2023 | Dec 31, 2023 | €18.80M | -36.9% |
| FY2022 | Dec 31, 2022 | €29.79M | -20.0% |
| FY2021 | Dec 31, 2021 | €37.24M | +140.8% |
| FY2020 | Dec 31, 2020 | €15.47M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | €28.15M | +49.7% |
| Q2 FY2025 | Jun 30, 2025 | €17.70M | -20.3% |
| Q4 FY2024 | Dec 31, 2024 | €12.70M | -57.4% |
| Q2 FY2024 | Jun 30, 2024 | €16.91M | -51.2% |
| Q4 FY2023 | Dec 31, 2023 | €18.80M | -49.5% |
| Q2 FY2023 | Jun 30, 2023 | €22.21M | +43.6% |
| Q4 FY2022 | Dec 31, 2022 | €29.79M | – |
| Q2 FY2022 | Jun 30, 2022 | €34.67M | – |
| Q4 FY2021 | Dec 31, 2021 | €37.24M | – |
| Q4 FY2020 | Dec 31, 2020 | €15.47M | – |
See a number that looks wrong?